PolyPeptide Group AG
SIX:PPGN

Watchlist Manager
PolyPeptide Group AG Logo
PolyPeptide Group AG
SIX:PPGN
Watchlist
Price: 30.9 CHF -2.37% Market Closed
Market Cap: 1B CHF
Have any thoughts about
PolyPeptide Group AG?
Write Note

Gross Margin
PolyPeptide Group AG

9.3%
Current
17%
Average
43.8%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
9.3%
=
Gross Profit
30.3m
/
Revenue
327.3m

Gross Margin Across Competitors

Country CH
Market Cap 1B CHF
Gross Margin
9%
Country US
Market Cap 1.4T USD
Gross Margin
55%
Country US
Market Cap 211.1B USD
Gross Margin
41%
Country US
Market Cap 177.9B USD
Gross Margin
60%
Country KR
Market Cap 71.2T KRW
Gross Margin
50%
Country CH
Market Cap 39.5B CHF
Gross Margin
29%
Country US
Market Cap 39.9B USD
Gross Margin
35%
Country US
Market Cap 39.4B USD
Gross Margin
55%
Country US
Market Cap 28.1B USD
Gross Margin
59%
Country US
Market Cap 24B USD
Gross Margin
64%
Country US
Market Cap 23.7B USD
Gross Margin
35%

Profitability Report

View the profitability report to see the full profitability analysis for PolyPeptide Group AG.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
9.3%
=
Gross Profit
30.3m
/
Revenue
327.3m
What is the Gross Margin of PolyPeptide Group AG?

Based on PolyPeptide Group AG's most recent financial statements, the company has Gross Margin of 9.3%.